Sichuan Biokin Pharmaceutical Co.,Ltd. (SHA:688506)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2014	FY 2013	FY 2012
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Pharmaceuticals	2.52B	5.82B	561.87M	703.28M	796.73M
Pharmaceuticals Growth	-56.72%	936.31%	-20.11%	-11.73%	-21.33%
Total	2.52B	5.82B	561.87M	703.28M	796.73M
Total Growth	-56.72%	936.31%	-20.11%	-11.73%	-21.33%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2014	FY 2013	FY 2012
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
China	380.08M	-	-	703.28M	796.73M
China Growth	-	-	-	-11.73%	-21.33%
Overseas	2.12B	-	-	-	-
Total	2.50B	-	-	703.28M	796.73M
Total Growth	-	-	-	-11.73%	-21.33%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 20, 2026

Data Sources Report a data error